Cystic Fibrosis Cf clinical trials

Explore recruiting cystic fibrosis cf clinical trials.

Recruiting cystic fibrosis cf studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cystic Fibrosis Cf trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase II trial to assess the activity and tolerability of Thymosin alpha 1 in Cystic Fibrosis Patients

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3 Open-label Study Evaluating the Long term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 2 Years and Older

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase IIa, randomized, placebo-controlled, double-blind, cross-over study to evaluate safety and efficacy of subcutaneous administration of anakinra in patients with cystic fibrosis (ANAKIN)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects with Chronic Pseudomonas aeruginosa (PsA) Pulmonary Infection

Germany, Ireland, France, Czechia, Italy, Netherlands +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Cystic Fibrosis Cf trials by city

Cystic Fibrosis Cf in Toronto Cystic Fibrosis Cf in Vancouver Cystic Fibrosis Cf in Montreal Cystic Fibrosis Cf in Calgary Cystic Fibrosis Cf in Edmonton Cystic Fibrosis Cf in Ottawa Cystic Fibrosis Cf in Winnipeg Cystic Fibrosis Cf in Quebec City Cystic Fibrosis Cf in Hamilton Cystic Fibrosis Cf in Kitchener Cystic Fibrosis Cf in London Cystic Fibrosis Cf in Halifax Cystic Fibrosis Cf in New York Cystic Fibrosis Cf in Los Angeles Cystic Fibrosis Cf in Chicago Cystic Fibrosis Cf in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease